Inorganic Chemistry Communications
journal homepage: www.elsevier.com/locate/inoche
Synthesis, characterization of sodium and potassium complexes and the application
in ring-opening polymerization of L-lactide
a
a
a
a
b
,a
,a
⁎
⁎
Longhai Chen , Lei Jia , Feixiang Cheng , Lei Wang , Chu-chieh Lin , Jincai Wu , Ning Tang
a
Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, State Key Laboratory of Applied Organic Chemistry,
College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, PR China
b
Department of Chemistry, National Chung Hsing University, Taichung 402, Taiwan, ROC
a r t i c l e i n f o
a b s t r a c t
Article history:
A novel sterically bulky phenol (2,4-di-tert-butyl-6-(1-(3,5-di-tert-butyl-2-(2-(2-methoxyethoxy)ethoxy)
phenyl)ethyl)phenol)(HL) and corresponding dimeric sodium and potassium complexes [ML]2 (1: M=Na, 2:
M=K) have been prepared and structurally characterized. Experimental results showed that complexes 1
and 2 can efficiently initiate the ring-opening polymerization of lactide in a controlled fashion, yielding
polymers with expected molecular weight and low polydispersity indexes.
Received 21 August 2010
Accepted 20 September 2010
Available online 29 September 2010
Keywords:
Sodium
© 2010 Elsevier B.V. All rights reserved.
Potassium
Catalyst
Lactide
Ring-opening polymerization
Polylactide (PLA) is one of the most important biodegradable materials
for its wide applications in biomedical and pharmaceutical fields [1], and
over the past three decades much attention has been devoted to the
development of new catalytic/initiating systems for the preparation of
polylactide (PLA). Among several catalytic systems reported previously,
the ring-opening polymerization (ROP) of lactide is the most effective
method for the synthesis of PLA [2]. Many metal complexes have been
used to initiate/catalyze ring-opening polymerization of lactides due to
the advantages of well controlled molecular weight and low polydisper-
sity index (PDI) [3]. As a result, a variety of metal complexes coordinated
with sterically bulky ligands such as β-diketiminate, salen, diol, etc., have
been developed and used as catalytic/initiating systems for the ROP of
lactides [4]. Although these complexes are excellent catalysts for the ROP
of lactides with high yields, their utilization to some extent is limited by
difficulties in removal of the catalyst from the resultant polymers as well
as the toxicity of metal cation [5]. To address this issue, many attempts
have been made to discover the nontoxic metal complexes (e.g., sodium
[6], potassium [7], magnesium [8], calcium [9], iron [10]) and highly active
metal-free [11] catalysts for the ROP of lactides. Due to the fact that sodium
and potassium cations are nontoxic, essential for life and also readily
available, sodium and potassium cations are preferentially selected as one
component of metal complex catalyst during our investigation on the
development of novel effective catalysts for ROP of lactides. EDBPH2 is an
interesting ligand because it has been approved as an indirect food
additive (as an antioxidant in polymer packaging) by the U.S. Food and
Drug Administration [12], and some of its metal complexes are excellent
catalysts with good controlled features for ROP of cyclic ester [13]. Based
on these views, we have designed and synthesized a novel sterically bulky
monovalent phenol ligand derived from EDBPH2 and its related nontoxic
sodium and potassium catalysts. The catalytic activities of sodium and
potassium complexes towards ROP of lactides have been investigated, and
the positive experimental results have proved that two designed catalysts,
especially with sodium cation, are effective in the current ROP of lactides.
According to the previous studies, a novel sterically bulky phenol
and the corresponding metal complexes were prepared in an almost
quantitative yield (Scheme 1) 1 [14]. Single crystals of 1 and 2 suitable
1
(a) Data for ligand 3: (0.481 g, 89% Yield). 1H NMR (300 MHz, CDCl3): δ 7.27 (1H, d,
J=2.4Hz, ArH); 7.23 (1H, d, J=2.4Hz, ArH); 7.13 (1H, d, J=2.4Hz, ArH); 7.09 (1H, d,
J=2.4Hz, ArH); 4.68 (1H, q, J=7.2Hz, CH); 4.14–4.02 (2H, m, CH2); 4.02–3.89 (2H, m, CH2);
3.82–3.78 (2H, m, CH2); 3.68–3.63 (2H, m, CH2); 3.36 (3H, s, CH3); 1.71 (3H, d, J=6.9Hz,
CH3); 1.38 (9H, s, C(CH3)3); 1.36 (9H, s, C(CH3)3); 1.29 (9H, s, C(CH3)3); 1.24 (9H, s, C(CH3)3).
13C NMR (75 MHz, CDCl3): δ 151.13; 150.68; 146.58; 141.63; 140.95; 138.00; 135.24; 131.24;
123.34; 122.29; 121.28; 120.19; 74.95; 72.01; 71.09; 70.32; 59.03; 35.39; 35.06; 34.58; 34.35;
31.74; 31.40; 29.73; 20.83. LC–MS: m/z 558.2 [M+NH4]+. Anal. Calcd for C35H56O4: C, 77.73;
H, 10.44. Found: C, 77.69; H, 10.42. (b) Data for sodium complex 1: (0.596 g, 91% Yield). 1
H
NMR (300 MHz, CDCl3): δ 7.46(2H, br, ArH);7.23 (2H, br, ArH); 7.18 (2H, br, ArH); 6.99 (2H, s,
ArH); 4.68 (2H, br, CH); 3.96 (4H, br, CH2); 3.86 (4H, br, CH2); 3.68 (4H, br, CH2); 3.55 (4H, br,
CH2); 3.37 (6H, s, CH3);2.81 (6H, s, CH3); 1.44 (18H, s, C(CH3)3); 1.40 (18H, s, C(CH3)3); 1.36
(18H, s, C(CH3)3); 1.26 (18H, s, C(CH3)3). 13CNMR(75 MHz,CDCl3): δ152.13; 151.68; 148.48;
143.63; 141.85; 138.70; 135.44; 132.04; 123.64; 122.89; 121.48; 120.39; 76.88; 72.13; 71.14;
59.06; 35.56; 35.87; 35.00; 34.63; 34.03; 31.90; 31.86; 21.75; 14.43 Anal. calcd for
C70H110Na2O8: C, 74.69; H, 9.85. Found: C, 74.60; H, 9.83. (c) Data for complex 2: Yield 87%.
1H NMR (300 MHz, CDCl3): 1H NMR (300 MHz, CDCl3): δ7.51(2H, br, ArH);7.33 (2H, br, ArH);
7.24 (2H, br, ArH); 6.98(2H, s, ArH); 4.73 (2H, br, CH); 4.12 (4H, br, CH2); 3.95 (4H, br, CH2);
3.67 (4H, br, CH2); 3.61 (4H, br, CH2); 3.42 (6H, s, CH3);2.83 (6H, s, CH3); 1.53 (18H, s, C
(CH3)3); 1.46 (18H, s, C(CH3)3); 1.40 (18H, s, C(CH3)3); 1.28 (18H, s, C(CH3)3). 13C NMR (75
MHz, CDCl3): δ 153.13; 152.18; 149.08; 143.73; 141.65; 138.77; 135.64; 132.14; 123.84;
122.79; 121.86; 120.99; 76.96; 72.23; 71.44; 59.86; 36.06; 35.88; 35.67; 34.93; 34.53; 31.96;
32.06; 21.95; 14.83 Anal. calcd for C70H110K2O8: C, 72.62; H, 9.58. Found: C, 72.60; H, 9.51.
⁎
Corresponding author. Fax: +86 931 8912582.
1387-7003/$ – see front matter © 2010 Elsevier B.V. All rights reserved.